Home  » Companies  » Biocon Ltd.

Biocon Ltd.

Price on BSE   16 Oct,15:29 LIVE
350.00
-1.50
(-0.43%)

© 2026 Rediff.com
  • Volume :
  • 668,342.00
  • Prev Close :
  • 351.50
  • Day's H/L (Rs.) :
  • 352.95 - 348.10
  • 52wk H/L (Rs.) :
  • 447.00 - 337.95
  • Mkt Cap (Rs. Cr) :
  • 57,039.50
Price on NSE   16 Oct,15:31 LIVE
349.20
-2.80
(-0.80%)

© 2026 Rediff.com
  • Volume :
  • 1,874,619.00
  • Prev Close :
  • 352.00
  • Day's H/L (Rs.) :
  • 353.00 - 348.00
  • 52wk H/L (Rs.) :
  • 447.15 - 337.70
  • Mkt Cap (Rs. Cr) :
  • 0.00

View more

Market News

HSBC emerges as top international bank for Indian corporate fundraising
Rediff.com   5 day(s) ago
Lupin eyes $500 million from biosimilars, expands global footprint
Rediff.com   15 Sep 2026
Indian drugmakers in no rush to shift to US despite tariff threat
Rediff.com   10 Aug 2026
Report Card - Biocon Ltd.
PE Ratios
1,525.13
EPS (Rs.)
0.23
Sales (Rs. Cr)
624.50
Face Value (Rs.)
5
Net Profit Margin(%)
1.58
Last Bonus
1:1
Last Dividend(%)
10
Return on Average Equity
0.13

News for Biocon Ltd.

Biocon Settles Patent Dispute for Breast Cancer Drug Pebrilzo
Biocon reaches global patent settlement with Genentech for its breast cancer biosimilar, Pebrilzo. Launches planned for EU/UK (2027) and US (2028).
Oct 14, 2026 13:13
Biocon Receives Rs 3.2 Cr GST Demand Notice for FY23
Biotechnology firm Biocon has been issued a GST demand notice of over Rs 3.2 crore, including interest and penalty, for the 2022-23 financial year. The company plans to appeal.
Oct 10, 2026 20:16
Indian Pharma Shifts to Innovation-Led Growth: Leaders Say
Industry leaders foresee India's pharma sector transitioning from generics to innovation, driven by R&D, talent, and supportive policies. A critical decade ahead.
Oct 05, 2026 13:42
Biocon Malaysia Gets UK MHRA Approval for Insulin Unit
Biocon Malaysia secures UK MHRA approval for its new fill-finish unit for Semglee (insulin glargine). This follows earlier EMA approval for the facility.
Sep 25, 2026 13:27
Biocon's Pebrilzo Gets Positive EMA Panel Nod for Breast Cancer
Biocon Biologics' Pebrilzo, a Pertuzumab biosimilar for HER2-positive breast cancer, receives positive EMA panel recommendation, moving closer to EU approval.
Sep 21, 2026 12:10

More News for Biocon Ltd. »

About Biocon Ltd.

Biocon Limited is an Indian biopharmaceutical company based in Bangalore. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets. Wikipedia

News for Pharmaceuticals

KTM Opens New Motorcycle Plant in Brazil: 20,000 Units/Year
KTM, owned by Bajaj Auto, launches a new CKD motorcycle assembly plant in Manaus, Brazil, with an annual capacity of 20,000 units for KTM & Husqvarna.
Oct 17, 2026 22:18
FSSAI Proposes New Pesticide Limits for Tea: Acetamiprid & Imidacloprid
FSSAI proposes draft MRLs for Acetamiprid (20 mg/kg) and Imidacloprid (50 mg/kg) in tea to ensure food safety while supporting crop protection.
Oct 17, 2026 21:59
Tata Trusts to Build 50 Not-for-Profit Hospitals, Focus on Impact
Tata Trusts plans 40-50 not-for-profit hospitals, shifting philanthropy to measurable impact. Chairman Noel Tata emphasizes effectiveness & institution building.
Oct 17, 2026 21:45
Yes Bank Q2 Net Profit Jumps 63% to Rs 1,084 Cr; AT1 Bond Impact
Yes Bank reports a 63.2% rise in Q2 FY27 net profit to Rs 1,084 crore, but results exclude potential impact of Supreme Court's AT1 bond ruling.
Oct 17, 2026 21:36
Pharma & Healthcare Hiring Up 20% for Specialized Talent
Hiring in India's pharma and life sciences sector surged 20% (Apr-Sep), driven by demand for specialized mid-career talent in AI/ML, R&D, and regulatory roles.
Oct 17, 2026 20:58

More News »

Top News

KTM Opens New Motorcycle Plant in Brazil: 20,000 Units/Year
KTM, owned by Bajaj Auto, launches a new CKD motorcycle assembly plant in Manaus, Brazil, with an annual capacity of 20,000 units for KTM & Husqvarna.
Oct 17, 2026 22:18
FSSAI Proposes New Pesticide Limits for Tea: Acetamiprid & Imidacloprid
FSSAI proposes draft MRLs for Acetamiprid (20 mg/kg) and Imidacloprid (50 mg/kg) in tea to ensure food safety while supporting crop protection.
Oct 17, 2026 21:59
MSM Unify India Acquires KlickEdu & RJ Vision Stakes
MSM Unify India expands its education network by acquiring majority stakes in KlickEdu (healthcare) and RJ Vision (entrance exams), boosting its presence.
Oct 17, 2026 21:50
Tata Trusts to Build 50 Not-for-Profit Hospitals, Focus on Impact
Tata Trusts plans 40-50 not-for-profit hospitals, shifting philanthropy to measurable impact. Chairman Noel Tata emphasizes effectiveness & institution building.
Oct 17, 2026 21:45
Yes Bank Q2 Net Profit Jumps 63% to Rs 1,084 Cr; AT1 Bond Impact
Yes Bank reports a 63.2% rise in Q2 FY27 net profit to Rs 1,084 crore, but results exclude potential impact of Supreme Court's AT1 bond ruling.
Oct 17, 2026 21:36

More Top News »

Our Services

News Movies Sports Cricket Business Get Ahead Gurus Astrology Rediff-Tv Business Email Rediff Podcast Payments